October 2018 - Page 19 of 30

ThursdayOct 11, 2018 9:51 am

665 Energy, Inc. (SSOF) Building Momentum as Energy Industry Supplier, Resale Business

665 Energy, Inc. positioned to supply upstream, midstream and downstream clients in oil and gas industry Global market for oil industry supplies expected to grow to $205 billion by 2020 Company also advancing plans to expand into purchase, refurbish and resale of oil drilling rigs The energy industry continues to form the bedrock of life-improving technological innovation more than a century after the end of the second Industrial Revolution, propelling global economies in which rapid transportation, mass manufacture and space satellite-enabled communication combine to elevate the standard of living for people around the world. As modern clean energy proponents work…

ThursdayOct 11, 2018 9:36 am

QualityStocksNewsBreaks – FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) Investee Adds Taxation Reporting Technology to its Proprietary Compliance Platform

FinCanna Capital (CSE: CALI) (OTCQB: FNNZF), a royalty company for the U.S. licensed medical cannabis industry, this morning announced that its investee company ezGreen Compliance has expanded its proprietary Business Intelligence Dashboard (“BID”) by adding a new comprehensive taxation feature to automate crucial revenue reporting functionality. ezGreen Compliance provides a state-of-the-art enterprise compliance and point-of-sale (“POS”) software solution for licensed medical cannabis dispensaries and cultivators. ezGreen plans to roll out the new taxation feature as a fully integrated component of its BID to the company’s affiliate network comprised of more than 200 dispensary locations. Furthermore, ezGreen’s BID, which was developed…

ThursdayOct 11, 2018 9:17 am

Argentina Proving to be a Land of Opportunity for Marifil Mines Ltd. (TSX.V: MFM) (OTCQB: MFMLF)

Marifil Mines’ primary exploration goals involve high-demand gold, lithium and cobalt targets Argentina is the third-largest gold producer in South America and anticipates most of its geological potential has yet to be tapped Canada-based Marifil has numerous project sites throughout Argentina in search for gold, lithium, cobalt, nickel, platinum, silver, phosphate and potassium Argentina’s nascent mining industry is proving to be a land of opportunity for Canadian explorer Marifil Mines Ltd. (TSX.V: MFM) (OTCQB: MFMLF), which has projects established throughout the country and most recently has been evaluating the gold and silver prospects of its property in the country’s southeastern…

WednesdayOct 10, 2018 12:45 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Infuses Cannabis Industry, Delivers Results with Innovative Drug Delivery Platform

Global legal cannabis market projected to surpass $146 billion by end of 2025 Cannabinoid-infused edibles, concentrates represent fastest-growing segment of industry Lexaria’s patented technology improves bio-absorption and bioavailability of active ingredients while masking unpleasant taste Lucrative licensing business model includes agreements to enhance cannabinoid (CBD) delivery before year-end 2018 Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) and its proprietary technology found in the company’s drug delivery platform DehydraTECH has application for several subsets of the cannabis industry and other pharmacological verticals. As a technology proven to deliver increased intestinal absorption rates and higher bioavailability for a number of bioactive compounds,…

WednesdayOct 10, 2018 12:27 pm

VistaGen Therapeutics, Inc. (NASDAQ: VTGN) Moves Forward in Developing As-Needed Treatment for Social Anxiety Disorder

Company signs a worldwide licensing agreement with Pherin Pharmaceuticals for the development and commercialization of a Phase 3-ready CNS drug candidate for as-needed treatment of social anxiety disorder Untreated social anxiety disorder has a significant impact on a person’s overall quality of life Clinical studies support the potential of PH94B to be a superior treatment alternative for SAD due to the demonstrated rapid onset of efficacy, route of administration, as-needed dosing convenience and excellent safety profile VistaGen Therapeutics, Inc. (NASDAQ: VTGN) is a clinical-stage biopharmaceutical company developing new generation medicines for depression and other central nervous system (CNS) diseases and…

WednesdayOct 10, 2018 12:00 pm

QualityStocksNewsBreaks – First Cobalt Corp. (TSX.V: FCC) (OTCQX: FTSSF) Announces Results of Independent Studies Supporting Restart of Canadian Refinery

First Cobalt Corp. (TSX.V: FCC) (OTCQX: FTSSF) (ASX: FCC), a vertically integrated North American pure-play cobalt company, this morning announced the results of three studies supporting a restart of the First Cobalt Refinery in Ontario, Canada. Per the update, the three independent studies were undertaken to estimate the capital requirements, operating costs, permit renewal timelines, potential feedstock options and offtake opportunities presented by the refinery. The permitting review concluded that a restart is possible within 18 months of selecting a feedstock under the base case scenario. “The First Cobalt Refinery is a strategic North American asset and potentially our quickest…

WednesdayOct 10, 2018 11:59 am

ChineseInvestors.com, Inc.’s (CIIX) CBD Biotechnology Co. Ltd. Sets December Launch for CBD Hemp-Infused Rice Wine, Sees it as ‘Sales Driver’

CIIX’s wholly owned foreign enterprise, CBD Biotechnology Co. Ltd. (CBD Biotech), will debut new private label wine at peak period for liquor sales in China Company recorded sales of $2.35 million for FY2018, up 41 percent from $1.66 million the prior year Summer Yun, CEO of CBD Biotech, anticipates greater volume during the top sales season for liquor ChineseInvestors.com, Inc.’s (OTCQB: CIIX) CBD Biotech, a wholly owned foreign enterprise, plans to debut a CBD hemp-infused rice wine in December, during China’s peak holiday/festival season that includes Christmas, New Year’s, and Spring Festival (http://ibn.fm/xUF36). In a news release, Warren Wang, CEO of…

WednesdayOct 10, 2018 11:31 am

Net Element, Inc. (NASDAQ: NETE) to Launch Third Party Bank Processing Service in Russia

A partnership with Sputnik Bank in Russia will enable the provision of third party bank processing services to local banks Regulatory approval and completion of the agreement are expected in the final quarter of 2018 Net Element is the only Nasdaq-listed U.S. company that stands to benefit from the Russian electronic payment expansion Global technology and value-added solutions group Net Element, Inc. (NASDAQ: NETE) recently announced a partnership with Sputnik Bank in Russia that’s aimed at offering third party bank processing to other banks in the country. As the October 2 announcement states, Net Element will get 25 percent of…

WednesdayOct 10, 2018 11:24 am

QualityStocksNewsBreaks – The Flowr Corporation (TSX.V: FLWR) Ships Initial Purchase Order from the NSLC

The Flowr Corporation (TSX.V: FLWR), a vertically integrated Canadian cannabis company, this morning reported that it has successfully shipped all the requested product from the initial purchase order of the Nova Scotia Liquor Corporation (“NSLC”). The NSLC is the provincial authority that controls adult recreational-use cannabis sales and retail outlets in Nova Scotia. Flowr was selected by the NSLC in August to sell premium cannabis through the province’s retailer. “We’re very pleased the NSLC recognized our ability to deliver high quality cannabis in the volumes it needs to meet the current demands of Nova Scotian consumers,” The Flowr Corporation Co-Founder…

WednesdayOct 10, 2018 11:17 am

DEA Decision to Remove Some Cannabidiol from Most Restrictive Class of Controlled Substances May Have Far-Reaching Impact on the CBD Market

The U.S. Drug Enforcement Administration (DEA) ruling enables physicians to prescribe Epidiolex, a non-synthetic cannabis-derived medicine from United Kingdom-grown cannabis Cannabis entrepreneurs applaud the decision, even though it only applies to that specific drug; DEA decision requires approval of medications by the U.S. Food & Drug Administration (FDA) Several other CBD medications are in the pipeline for consideration by the FDA; move is seen as legitimizing the industry and changing it to traditional distribution of prescription-to-drug store The DEA decision to approve the first non-synthetic CBD-derived drug, Epidiolex, and remove it from the agency’s most restrictive class of controlled substances…

Site Search

Company Search

Month: October 2018